Harrow: VEVYE And Its Impact On The DED Market
Harrow Health(HROW) Seeking Alpha·2024-11-11 11:37
~Dr. John D. Sheppard, Ophthalmologist, President of Virginia Eye Consultants, and one of the investigators on the ESSENCE‑2 OLETopical cyclosporine has established a remarkable decades-long efficacy and safety profile. Finally, we have the right vehicle.About the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curat ...